Oceania Healthcare Limited (NZE:OCA)
New Zealand · Delayed Price · Currency is NZD 0.7550
+0.0150 (2.03%)
Jul 31, 2026, 5:00 PM NZST
Oceania Healthcare Income Statement
Financials in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 267.14 | 260.57 | 265.46 | 247.18 | 231.14 |
Other Revenue | 1.64 | 1.83 | - | - | - |
| 268.77 | 262.4 | 265.46 | 247.18 | 231.14 | |
Revenue Growth | 2.43% | -1.15% | 7.40% | 6.94% | 8.54% |
Cost of Revenue | 191.48 | 185.19 | 185.55 | 164.48 | 156.45 |
Gross Profit | 77.29 | 77.21 | 79.91 | 82.7 | 74.69 |
Selling, General & Admin | - | - | - | 0.16 | 2.5 |
Other Operating Expenses | 71.72 | 74.59 | 70.46 | 66.78 | 59.99 |
Operating Expenses | 95.46 | 96.74 | 89.45 | 84.86 | 81.11 |
Operating Income | -18.17 | -19.53 | -9.54 | -2.17 | -6.42 |
Interest Expense | -19.65 | -20.83 | -10.9 | -9.12 | -5.76 |
Interest & Investment Income | 1.05 | 3.11 | 4.54 | 1.76 | 0.08 |
Other Non Operating Income (Expenses) | -6.14 | -5.43 | -3.59 | -2.86 | -0.19 |
EBT Excluding Unusual Items | -42.92 | -42.68 | -19.48 | -12.38 | -12.29 |
Impairment of Goodwill | -0.1 | -0.2 | -0.56 | -2.35 | -0.41 |
Gain (Loss) on Sale of Assets | -7.23 | -0.85 | -5.77 | 2.63 | -0.03 |
Asset Writedown | 42.54 | 64.16 | 51.51 | 13.48 | 58.62 |
Other Unusual Items | - | 5.43 | - | -1.4 | 10.36 |
Pretax Income | -7.71 | 25.85 | 28.39 | 12 | 56.25 |
Income Tax Expense | -7.83 | -4.56 | -3.08 | -3.45 | -4.88 |
Net Income | 0.12 | 30.42 | 31.47 | 15.45 | 61.13 |
Net Income to Common | 0.12 | 30.42 | 31.47 | 15.45 | 61.13 |
Net Income Growth | -99.61% | -3.36% | 103.74% | -74.73% | -40.54% |
Shares Outstanding (Basic) | 724 | 724 | 723 | 715 | 705 |
Shares Outstanding (Diluted) | 724 | 724 | 724 | 716 | 705 |
Shares Change | - | 0.08% | 1.12% | 1.46% | 13.49% |
EPS (Basic) | 0.00 | 0.04 | 0.04 | 0.02 | 0.09 |
EPS (Diluted) | 0.00 | 0.04 | 0.04 | 0.02 | 0.09 |
EPS Growth | -99.61% | -2.33% | 99.12% | -75.08% | -47.61% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 151.57 | 70.04 | 50.17 | 14.1 | 49.23 |
Free Cash Flow Per Share | 0.21 | 0.10 | 0.07 | 0.02 | 0.07 |
Dividend Per Share | - | - | - | 0.032 | 0.044 |
Dividend Growth | - | - | - | -27.27% | 7.84% |
Gross Margin | 28.76% | 29.42% | 30.10% | 33.46% | 32.31% |
Operating Margin | -6.76% | -7.44% | -3.59% | -0.88% | -2.78% |
Profit Margin | 0.04% | 11.59% | 11.86% | 6.25% | 26.45% |
Free Cash Flow Margin | 56.39% | 26.69% | 18.90% | 5.71% | 21.30% |
EBITDA | 2.52 | -0.51 | 6.78 | 13.02 | 9.02 |
EBITDA Margin | 0.94% | -0.19% | 2.55% | 5.27% | 3.90% |
D&A For EBITDA | 20.7 | 19.02 | 16.32 | 15.19 | 15.44 |
EBIT | -18.17 | -19.53 | -9.54 | -2.17 | -6.42 |
EBIT Margin | -6.76% | -7.44% | -3.59% | -0.88% | -2.78% |
Revenue as Reported | 302.63 | 355.68 | 335.41 | 285.97 | 308.48 |